9/14/2026
Psyence BioMed expands U.S. ibogaine research with Texas unit
New subsidiary aims to centralize ibogaine supply and regulatory efforts in the U.S.
Topic archive
psyence biomedical ltd.
5 stories
9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.
9/2/2026
Psyence Biomedical files SEC document
The filing could signal strategic developments for the company.
8/19/2026
Psyence BioMed supports U.S. push for ibogaine development
U.S. federal actions could accelerate ibogaine's medical potential
8/7/2026
Psyence Biomedical unveils strategic plans in new investor presentation
Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.